DT
Degron Therapeutics
China · Biotech · Healthtech · Enterprise software
Develops molecular glue degrader medicines targeting previously undruggable proteins
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A+ | $40M | ApicHope — Role not disclosedCASSTAR — Role not disclosedCSPC & Growth — Role not disclosedFortune Capital — Role not disclosedGAGE Capital — Role not disclosedGF Xinde — Role not disclosedGTJA Investment Group — Role not disclosedKinghall Ventures — Role not disclosedLAPAM CAPITAL — Role not disclosed |